Format

Send to

Choose Destination
Sci Transl Med. 2012 Feb 29;4(123):123ps4. doi: 10.1126/scitranslmed.3003862.

CD4+ T cells and HIV: A paradoxical Pas de Deux.

Author information

1
Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Abstract

When it comes to HIV infection, CD4(+) T cells are usually thought of as the cells that are preferentially infected and killed by the virus. In a new study, Soghoian et al. now show that during the early stages of HIV infection, CD4(+) T cells suppress virus replication and delay disease onset. Thus, the robustness of the CD4(+) T cell response during early HIV infection could be used as a marker to determine the speed of disease progression. The new findings also have implications for the design of preventive and therapeutic AIDS vaccines.

PMID:
22378922
DOI:
10.1126/scitranslmed.3003862
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center